Gregory E. Simon, MD, MPH

Simon_Gregory_E_205x293.jpg

“We bring a practical approach to mental health research, working to break down barriers between research and real-world health care.”

Gregory E. Simon, MD, MPH

Senior Investigator, Kaiser Permanente Washington Health Research Institute
Psychiatrist, Washington Permanente Medical Group
Professor, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine
Research Professor, Psychiatry and Behavioral Sciences, University of Washington

Biography

Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness.  Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and reducing racial and ethnic disparities in mental health care.

Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, originally funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. The MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.

Dr. Simon and his MHRN colleagues have conducted several large studies across MHRN health systems, including:

  • A pragmatic trial in four health systems examining the effect of systematic outreach programs to prevent suicide attempt among people at high risk.
  • Using electronic health records from seven health systems to develop and validate machine learning models to identify people at high risk of suicidal behavior.
  • A pragmatic trial in two health systems evaluating electronic health record tools to reduce risk of cardiovascular disease in people with bipolar disorder and schizophrenia.
  • A rigorous evaluation of Zero Suicide care improvement programs in six health systems
  • Developing measures to assess quality of care for depression in two health systems.

Dr. Simon sits on the editorial board for the journal General Hospital Psychiatry, and co-chairs the National Academy of Medicine’s Forum on Drug Discovery, Development and Translation.. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990.  He is also a professor in the department of Health Systems Science at the Bernard J Tyson Kaiser Permanente School of Medicine and an adjunct  professor inPsychiatry and Behavioral Dciences at the University of Washington.​​​

Research interests and experience

  • Mental Health

    Depression; bipolar disorder; suicide prevention; self-management; treatment adherence

  • Chronic Illness Management

    Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.

Recent publications

Widome R, Linde JA, Rohde P, Ludman EJ, Jeffery RW, Simon GE. Does the association between depression and smoking vary by body mass index (BMI) category?  Prev Med. 2009;49(5):380-3. Epub 2009 Jul 30. PubMed

Simon G. Review: second-generation antidepressants have similar effectiveness, but specific adverse effects differed.  Evid Based Med. 2009;14(3):82. PubMed

Simon GE. CBT improves maternal perinatal depression in rural Pakistan.  Evid Based Ment Health. 2009;12(2):45. PubMed

Ralston JD, Rutter CM, Carrell D, Hecht J, Rubanowice D, Simon GE. Patient use of secure electronic messaging within a shared medical record: a cross-sectional study.  J Gen Intern Med. 2009;24(3):349-55. Epub 2009 Jan 10. PubMed

Simon G. Collaborative care for mood disorders. Curr Opin Psychiatry. 2009;22(1):37-41. PubMed

Simon G, Rutter C, Crosier M, Scott J, Operskalski BH, Ludman E. Are comparisons of consumer satisfaction with providers biased by nonresponse or case-mix differences?  Psychiatr Serv. 2009;60(1):67-73. PubMed

Arterburn D, Ichikawa L, Ludman E, Operskalski B, Linde J, Anderson E, Rohde P, Jeffery R, Simon G. Validity of clinical body weight measures as substitutes for missing data in a randomized trial. Obesity Research and Clinical Practice. 2008;10(4):277-81. PubMed

Rohde P, Ichikawa L, Simon GE, Ludman EJ, Linde JA, Jeffery RW, Operskalski BH. Associations of child sexual and physical abuse with obesity and depression in middle-aged women.  Child Abuse Negl. 2008;32(9):878-87. Epub 2008 Oct 22. PubMed

Mauskopf JA, Simon GE, Kalsekar A, Nimsch C, Dunayevich E, Cameron A. Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder.  Depress Anxiety. 2009;26(1):83-97. Epub 2008 Oct 2. PubMed

Simon GE, Ludman EJ, Unutzer J, Operskalski BH, Bauer MS. Severity of mood symptoms and work productivity in people treated for bipolar disorder.  Bipolar Disord. 2008;10(6):718-25. PubMed

 

Research

Zero_suicide_1col.png

Researchers have a proven prescription for reducing suicide rates

In a new multistate study, the Zero Suicide Model reduced suicide rates by 25%.

Research

Integrating_suicide_care_in_primary_care_1col.jpg

Suicide attempts decreased after adding suicide care to primary care

Safety planning and risk screening improved outcomes for adult patients.

Research

Treatment_for_depression_1col.jpg

Can machine learning help treat depression more effectively?

A new grant funds modeling work to make personalized treatment possible.

Research

Lock_to_Live_Doctor_and_Patient_1col.jpg

Understanding adoption of Lock to Live, a decision aid supporting suicide prevention

KPWHRI research finds ways to increase use of a firearm safety tool.

Research

clozapine-story_1col.jpg

A medication that can relieve symptoms of psychosis is underused

Study finds that many patients who might benefit from clozapine don’t receive it.